Use of attention-deficit/hyperactivity disorder medication among older adults in Denmark

British Journal of Clinical Pharmacology
Stina Schultz OrmhøjLotte Rasmussen

Abstract

Knowledge on the use of attention-deficit/hyperactivity disorder (ADHD) medication among older adults is limited. We hypothesized that ADHD medication is used off-label in adults aged ≥50 years as part of palliative care in e.g. cancer patients. The aim of this study was to describe the use of ADHD medication among adults aged ≥50 years in Denmark. Using the Danish health registries, we identified new users ≥50 years of ADHD medication during 2000-2012. We estimated the annual incidence of ADHD medication use and ADHD diagnoses. We described new users of ADHD medication according to co-medication, comorbidities and assessed the 1-year cumulative mortality rate. A posthoc analysis allowed us to include new users until 2015. We identified 6690 new users of ADHD medication from 2000 to 2012. From 2000 to 2015 we observed an increase in the incidence of ADHD medication use from 12.5 to 30.3 per 100 000 person-years. However, the incidence rate decreased from 2010 to 2015. Throughout the study period, the incidence rate of ADHD diagnoses was low (overall prevalence among new users ≤2%). Opioids were the most frequent comedication used (used by 54%), while cancer was the most frequent diagnosis preceding treatment (prevalence of 52%)...Continue Reading

References

Nov 6, 1998·British Journal of Clinical Pharmacology·D J van KraaijW H Hoefnagels
Oct 30, 2001·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·F StiefelA Razavi
Jan 5, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark RozansMarc J Kahn
Jan 25, 2008·Palliative Medicine·Lukas RadbruchUNKNOWN Research Steering Committee of the European Association for Palliative Care (EAPC)
Jul 29, 2008·Current Opinion in Supportive and Palliative Care·Sam H Ahmedzai, Jason Boland
Aug 4, 2011·Scandinavian Journal of Public Health·Ole MorsPreben Bo Mortensen
Sep 8, 2011·Scandinavian Journal of Public Health·Lau Caspar ThygesenHenrik Brønnum-Hansen
Dec 7, 2011·The American Journal of Hospice & Palliative Care·Eric Prommer
Mar 22, 2012·European Journal of Clinical Pharmacology·Anton PottegårdSøren Ilsøe Moreno
Jul 20, 2012·European Journal of Clinical Pharmacology·Anton PottegårdSøren Ilsøe Moreno
Jan 23, 2013·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Chong Guan NgNiek J de Wit
Feb 20, 2013·The Journal of Clinical Psychiatry·Mark OlfsonLaurence L Greenhill
Apr 3, 2014·Basic & Clinical Pharmacology & Toxicology·Drifa Palin GeirsHelga Zoëga
May 9, 2014·JAMA Psychiatry·Carsten Bøcker PedersenWilliam W Eaton
Jun 27, 2014·European Journal of Epidemiology·Morten SchmidtHenrik Toft Sørensen
Aug 19, 2015·Pharmacoepidemiology and Drug Safety·Lotte RasmussenAnton Pottegård
Nov 26, 2015·Clinical Epidemiology·Morten SchmidtHenrik Toft Sørensen
Apr 23, 2016·Acta Clinica Belgica·Maarten WautersMajda Azermai
Sep 3, 2016·European Journal of Clinical Pharmacology·Øystein KarlstadAnton Pottegård
Nov 29, 2016·International Journal of Epidemiology·Morten SchmidtSøren Friis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Related Papers

Diabetologia
B CarstensenSteering Group of the National Diabetes Register
Journal of the American Geriatrics Society
Evert J SemeijnAartjan T F Beekman
Diabetes Research and Clinical Practice
Otto Mølby HenriksenOle Lander Svendsen
European Archives of Psychiatry and Clinical Neuroscience
H J Möller
Journal of the American Academy of Child and Adolescent Psychiatry
S P CuffeC Z Garrison
© 2022 Meta ULC. All rights reserved